Pierre Fabre has a new partnership for its Open Innovation programme based on an extensive plant library. It will now count with VibioSphen to develop new phyto-chemicals to fight infectious diseases.
Pierre Fabre is the 3rd largest Pharma in France, employing over 10,000 people and generating revenues of over €2Bn.
Now, another Pierre Fabre’s innovation strategy is advancing with its second partnership (after Plasticell). The programme is the ‘Nature Open Library‘ and was launched in December. It intends to explore its 15,000-sample library of plants and phytochemical compounds (chemicals produced by plants).
The Biotech involved in this new partnership is VibioSphen,